| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |